Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff

REFERENCES

• Anderson, R. D., and Berger, N. A.. 1994. Mutagenicity and carcinogenicity of topoisomerase-interactive drugs. Mutat. Res. 309:109–142
   PubMed Web of Science ®Google Scholar
• Avemann, K., Knippers, R., Koller, T., and Sogo, J. M.. 1988. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks. Mol. Cell. Biol. 8:3026–3034
   PubMed Web of Science ®Google Scholar
• Baker, S. D., Wadkins, R. M., Stewart, C. F., Beck, W. T., and Danks, M. K.. 1995. Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy. Cytometry 19:134–145
   PubMedGoogle Scholar
• Bendixen, C., Thomsen, B., Alsner, J., and Westergaard, O.. 1990. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochemistry 29:5613–5619
   PubMedGoogle Scholar
• Bennett, C. B., Westmoreland, T. J., Snipe, J. R., and Resnick, M. A.. 1996. A double-strand break within a yeast artificial chromosome (YAC) containing human DNA can result in YAC loss, deletion, or cell lethality. Mol. Cell. Biol. 16:4414–4425
   PubMedGoogle Scholar
• Brush, G. S., and Kelly, T. J.. 1996. Mechanisms for replicating DNA. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
   Google Scholar
• Buckwalter, C. A., Lin, A. H., Tanizawa, A., Pommier, Y. G., Cheng, Y. C., and Kaufmann, S. H.. 1996. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. Cancer Res. 56:1674–1681
   PubMedGoogle Scholar
• Bullock, P., Champoux, J. J., and Botchan, M.. 1985. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination. Science 230:954–958
   PubMedGoogle Scholar
• Champoux, J. J., McCoubrey, W. K.Jr., and Been, M. D.. 1984. DNA structural features that lead to strand breakage by eukaryotic type-I topoisomerase. Cold Spring Harbor Symp. Quant. Biol. 49:435–442
   PubMedGoogle Scholar
• Chen, C. L., Fuscoe, J. C., Liu, Q., Pui, C. H., Mahmoud, H. H., and Relling, M. V.. 1996. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide. J. Natl. Cancer Inst. 88:1840–1847
   PubMed Web of Science ®Google Scholar
• Christiansen, K., Svejstrup, A. B., Andersen, A. H., and Westergaard, O.. 1993. Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. Cleavage of DNA substrates containing strand interruptions implicates a role for topoisomerase I in illegitimate recombination. J. Biol. Chem. 268:9690–9701
   PubMed Web of Science ®Google Scholar
• Cimmino, C., Santori, F., and Donini, P.. 1995. Ligation of nonmatching DNA molecule ends. Plasmid 34:1–10
   PubMedGoogle Scholar
• Covey, J. M., Jaxel, C., Kohn, K. W., and Pommier, Y.. 1989. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res. 49:5016–5022
   PubMedGoogle Scholar
• Culotta, V., and Sollner-Webb, B.. 1988. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure. Cell 52:585–597
   PubMed Web of Science ®Google Scholar
• Danks, M. K., Garrett, K. E., Marion, R. C., and Whipple, D. O.. 1996. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan. Cancer Res. 56:1664–1673
   PubMedGoogle Scholar
• D'Arpa, P., Beardmore, C., and Liu, L. F.. 1990. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50:6919–6924
   PubMed Web of Science ®Google Scholar
• Eng, W. K., Faucette, L., Johnson, R. K., and Sternglanz, R.. 1988. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol. 34:755–760
   PubMed Web of Science ®Google Scholar
• Gencheva, M., Anachkova, B., and Russev, G.. 1996. Mapping the sites of initiation of DNA replication in rat and human rRNA genes. J. Biol. Chem. 271:2608–2614
   PubMedGoogle Scholar
• Gerber, J. K., Gogel, E., Berger, C., Wallisch, M., Muller, F., Grummt, I., and Grummt, F.. 1997. Termination of mammalian rDNA replication: polar arrest of replication fork movement by transcription termination factor TTF-I. Cell 90:559–567
   PubMed Web of Science ®Google Scholar
• Gilmour, D. S., Pflugfelder, G., Wang, J. C., and Lis, J. T.. 1986. Topoisomerase I interacts with transcribed regions in Drosophila cells. Cell 44:401–407
   PubMedGoogle Scholar
• Gonzalez, I. L., and Sylvester, J. E.. 1995. Complete sequence of the 43-kb human ribosomal DNA repeat: analysis of the intergenic spacer. Genomics 27:320–328
   PubMedGoogle Scholar
• Gupta, M., Fujimori, A., and Pommier, Y.. 1995. Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta 1262:1–14
   PubMed Web of Science ®Google Scholar
• Hernandez, P., Martin-Parras, L., Martinez-Robles, M. L., and Schvartzman, J. B.. 1993. Conserved features in the mode of replication of eukaryotic ribosomal RNA genes. EMBO J. 12:1475–1485
   PubMedGoogle Scholar
• Holm, C., Covey, J. M., Kerrigan, D., and Pommier, Y.. 1989. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res. 49:6365–6368
   PubMed Web of Science ®Google Scholar
• Hsiang, Y. H., Hertzberg, R., Hecht, S., and Liu, L. F.. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873–14878
   PubMed Web of Science ®Google Scholar
• Hsiang, Y. H., Lihou, M. G., and Liu, L. F.. 1989. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:5077–5082
   PubMed Web of Science ®Google Scholar
• Lanza, A., Tornaletti, S., Rodolfo, C., Scanavini, M. C., and Pedrini, A. M.. 1996. Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage. J. Biol. Chem. 271:6978–6986
   PubMed Web of Science ®Google Scholar
• Little, R. D., Platt, T. H., and Schildkraut, C. L.. 1993. Initiation and termination of DNA replication in human rRNA genes. Mol. Cell. Biol. 13:6600–6613
   PubMedGoogle Scholar
• Liu, L. F., Duann, P., Lin, C. T., D'Arpa, P., and Wu, J.. 1996. Mechanism of action of camptothecin. Ann. N.Y. Acad. Sci. 803:44–49
   PubMed Web of Science ®Google Scholar
• Maxam, A. M., and Gilbert, W.. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560
   PubMedGoogle Scholar
• Meyer, K. N., Kjeldsen, E., Straub, T., Knudsen, B. R., Hickson, I. D., Kikuchi, A., Kreipe, H., and Boege, F.. 1997. Cell cycle-coupled relocation of type I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136:775–788
   PubMedGoogle Scholar
• Mueller, P. R., Garrity, P. A., and Wold, B.. 1992. Ligation-mediated PCR Current protocols in molecular biology. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seideman, J. G., Smith, J. A., and Struhl, K. 15.5.1–15.5.26 John Wiley & Sons, Inc., New York, N.Y
   Google Scholar
• Muller, M. T., Pfund, W. P., Mehta, V. B., and Trask, D. K.. 1985. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J. 4:1237–1243
   PubMedGoogle Scholar
• Nitiss, J. L.. 1998. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim. Biophys. Acta 1400:63–81
   PubMed Web of Science ®Google Scholar
• Osman, F., Fortunato, E. A., and Subramani, S.. 1996. Double-strand break-induced mitotic intrachromosomal recombination in the fission yeast Schizosaccharomyces pombe. Genetics 142:341–357
   PubMedGoogle Scholar
• Pommier, Y., Jenkins, J., Kohlhagen, G., and Leteurtre, F.. 1995. DNA recombinase activity of eukaryotic DNA topoisomerase I: effects of camptothecin and other inhibitors. Mutat. Res. 337:135–145
   PubMedGoogle Scholar
• Pommier, Y., Kohlhagen, G., Pourquier, P., Sayer, J. M., Kroth, H., and Jerina, D. M.. 2000. Benzo[a]pyrene epoxide adducts in DNA are potent inhibitors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc. Natl. Acad. Sci. USA 10:2040–2045
   Google Scholar
• Pommier, Y., Kohlhagen, G., Wu, C., and Simmons, D. T.. 1998. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen. Biochemistry 37:3818–3823
   PubMedGoogle Scholar
• Pommier, Y., Pourquier, P., Fan, Y., and Strumberg, D.. 1998. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400:83–105
   PubMed Web of Science ®Google Scholar
• Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J., and Laco, G.. 1999. Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Update 2:307–318
   PubMed Web of Science ®Google Scholar
• Pondarré, C., Strumberg, D., Fujimori, A., Torres-Leon, R., and Pommier, Y.. 1997. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells. Nucleic Acids Res. 25:4111–4116
   PubMedGoogle Scholar
• Porter, S. E., and Champoux, J. J.. 1989. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res. 17:8521–8532
   PubMed Web of Science ®Google Scholar
• Pouliot, J. J., Yao, K. C., Robertson, C. A., and Nash, H. A.. 1999. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topo I covalent complexes. Science 286:552–555
   PubMed Web of Science ®Google Scholar
• Pourquier, P., Bjornsti, M. A., and Pommier, Y.. 1998. Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine. J. Biol. Chem. 273:27245–27249
   PubMedGoogle Scholar
• Pourquier, P., Pilon, A. A., Kohlhagen, G., Mazumder, A., Sharma, A., and Pommier, Y.. 1997. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J. Biol. Chem. 272:26441–26447
   PubMed Web of Science ®Google Scholar
• Pourquier, P., Takebayashi, Y., Urasaki, Y., Gioffre, C., Kohlhagen, G., and Pommier, Y.. 2000. Induction of topoisomerase I cleavage complexes by 1-β-d-arabinofuranosylcytosine (Ara-C) in vitro and in ara-C-treated cells. Proc. Natl. Acad. Sci. USA 97:1885–1890
   PubMed Web of Science ®Google Scholar
• Pourquier, P., Ueng, L. M., Fertala, J., Wang, D., Park, H. J., Essigmann, J. M., Bjornsti, M. A., and Pommier, Y.. 1999. Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages: 7,8-dihydro-8-oxoguanine and 5-hydroxycytosine. J. Biol. Chem. 274:8516–8523
   PubMed Web of Science ®Google Scholar
• Pourquier, P., Ueng, L. M., Kohlhagen, G., Mazumder, A., Gupta, M., Kohn, K. W., and Pommier, Y.. 1997. Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J. Biol. Chem. 272:7792–7796
   PubMed Web of Science ®Google Scholar
• Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J., and Hol, W. G.. 1998. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279:1504–1513
   PubMed Web of Science ®Google Scholar
• Rosenstein, B. S., Subramanian, D., and Muller, M. T.. 1997. The involvement of topoisomerase I in the induction of DNA-protein crosslinks and DNA single-strand breaks in cells of ultraviolet-irradiated human and frog cell lines. Radiat. Res. 148:575–579
   PubMedGoogle Scholar
• Ryan, A. J., Squires, S., Strutt, H. L., and Johnson, R. T.. 1991. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res. 19:3295–3300
   PubMed Web of Science ®Google Scholar
• Sargent, R. G., Brenneman, M. A., and Wilson, J. H.. 1997. Repair of site-specific double-strand breaks in a mammalian chromosome by homologous and illegitimate recombination. Mol. Cell. Biol. 17:267–277
   PubMed Web of Science ®Google Scholar
• Sastry, S., and Ross, B. M.. 1998. Mechanisms for the processing of a frozen topoisomerase-DNA conjugate by human cell-free extracts. J. Biol. Chem. 273:9942–9950
   PubMedGoogle Scholar
• Shan, Q., and Cox, M. M.. 1998. On the mechanism of RecA-mediated repair of double-strand breaks: no role for four-strand DNA pairing intermediates. Mol. Cell 1:309–317
   PubMedGoogle Scholar
• Shao, R.-G., Cao, C.-X., Zhang, H., Kohn, K. W., Wold, M. S., and Pommier, Y.. 1999. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J. 18:1397–1406
   PubMedGoogle Scholar
• Shin, C. G., and Snapka, R. M.. 1990. Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks. Biochem. Biophys. Res. Commun. 168:135–140
   PubMedGoogle Scholar
• Shuman, S.. 1992. DNA strand transfer reactions catalyzed by vaccinia topoisomerase I. J. Biol. Chem. 267:8620–8627
   PubMed Web of Science ®Google Scholar
• Shuman, S.. 1992. Two classes of DNA end-joining reactions catalyzed by vaccinia topoisomerase I. J. Biol. Chem. 267:16755–16758
   PubMedGoogle Scholar
• Snapka, R. M., and Permana, P. A.. 1993. SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication. Bioessays 15:121–127
   PubMedGoogle Scholar
• Squires, S., Ryan, A. J., Strutt, H. L., and Johnson, R. T.. 1993. Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA. Cancer Res. 53:2012–2019
   PubMed Web of Science ®Google Scholar
• Stewart, L., Redinbo, M. R., Qiu, X., Hol, W. G., and Champoux, J. J.. 1998. A model for the mechanism of human topoisomerase I. Science 279:1534–1541
   PubMed Web of Science ®Google Scholar
• Subramanian, D., Rosenstein, B. S., and Muller, M. T.. 1998. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair. Cancer Res. 58:976–984
   PubMed Web of Science ®Google Scholar
• Svejstrup, J. Q., Christiansen, K., Andersen, A. H., Lund, K., and Westergaard, O.. 1990. Minimal DNA duplex requirements for topoisomerase I-mediated cleavage in vitro. J. Biol. Chem. 265:12529–12535
   PubMed Web of Science ®Google Scholar
• Svoboda, D. L., and Vos, J. M.. 1995. Differential replication of a single, UV-induced lesion in the leading or lagging strand by a human cell extract: fork uncoupling or gap formation. Proc. Natl. Acad. Sci. USA 92:11975–11979
   PubMedGoogle Scholar
• Sylvester, J. E., Petersen, R., and Schmickel, R. D.. 1989. Human ribosomal DNA: novel sequence organization in a 4.5-kb region upstream from the promoter. Gene 84:193–196
   PubMedGoogle Scholar
• Takebayashi, Y., Pourquier, P., Yoshida, A., Kohlhagen, G., and Pommier, Y.. 1999. Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove. Proc. Natl. Acad. Sci. USA 96:7196–7201
   PubMed Web of Science ®Google Scholar
• Tanizawa, A., Kohn, K. W., Kohlhagen, G., Leteurtre, F., and Pommier, Y.. 1995. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry 34:7200–7206
   PubMedGoogle Scholar
• Tsao, Y. P., Russo, A., Nyamuswa, G., Silber, R., and Liu, L. F.. 1993. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res. 53:5908–5914
   PubMed Web of Science ®Google Scholar
• Tsukamoto, Y., and Ikeda, H.. 1998. Double-strand break repair mediated by DNA end-joining. Genes Cells 3:135–144
   PubMedGoogle Scholar
• Veaute, X., and Sarasin, A.. 1997. Differential replication of a single N-2-acetylaminofluorene lesion in the leading or lagging strand DNA in a human cell extract. J. Biol. Chem. 272:15351–15357
   PubMedGoogle Scholar
• Wang, J. C.. 1996. DNA topoisomerases. Annu. Rev. Biochem. 65:635–692
   PubMed Web of Science ®Google Scholar
• Wu, J., and Liu, L. F.. 1997. Processing of topoisomerase I cleavable complexes into DNA damage by transcription. Nucleic Acids Res. 25:4181–4186
   PubMed Web of Science ®Google Scholar
• Yeh, Y. C., Liu, H. F., Ellis, C. A., and Lu, A. L.. 1994. Mammalian topoisomerase I has base mismatch nicking activity. J. Biol. Chem. 269:15498–15504
   PubMedGoogle Scholar
• Yoon, Y., Sanchez, J. A., Brun, C., and Huberman, J. A.. 1995. Mapping of replication initiation sites in human ribosomal DNA by nascent-strand abundance analysis. Mol. Cell. Biol. 15:2482–2489
   PubMedGoogle Scholar
• Zhang, H., Wang, J. C., and Liu, L. F.. 1988. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA 85:1060–1064
   PubMed Web of Science ®Google Scholar